-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Allarity Therapeutics, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2024.
- Allarity Therapeutics, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$14K.
- Allarity Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $97K.
- Allarity Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$1.61M, a 8160% decline from 2021.
- Allarity Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $20K, a 87.9% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)